Is there alternative to FOLFOX adjuvant chemotherapy for stage III colorectal cancer patients?

被引：0

作者：

Esch, Anouk ^{[1
]}

Coriat, Romain ^{[1
]}

Perkins, Geraldine ^{[1
]}

Brezault, Catherine ^{[1
]}

Chaussade, Stanislas ^{[1
]}

机构：

[1] CHU Cochin Port Royal, Serv Gastroenterol, F-75014 Paris, France

来源：

PRESSE MEDICALE | 2012年 / 41卷 / 01期

关键词：

CAPECITABINE PLUS OXALIPLATIN; COLON-CANCER; MICROSATELLITE INSTABILITY; LYMPH-NODES; PHASE-III; SURVIVAL; FLUOROURACIL; THERAPY; RESECTION; TRIAL;

D O I：

10.1016/j.lpm.2011.03.021

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Is there alternative to FOLFOX adjuvant chemotherapy for stage III colorectal cancer patients? Being the second cancer for men and the third cancer for women in France, colorectal cancer represents a serious public health issue. its incidence has increased these last years and despite new therapeutics being developed, it still has a bad prognostic. Thanks in part to Hemoccult national mass screening program, its diagnosis is made possible at an earlier stage, which makes a surgical curative resection and the carrying out of adjuvant chemotherapy possible. For stage III colic cancer that has been surgically removed, adjuvant chemotherapy by FOLFOX 4 has to be offered. Nevertheless, because of its toxicities, the patient's high age, important comorbidities or post-surgical complications, this chemotherapy occasionally cannot be done. What ore the colorectal cancer prognostic factors which would guide the chemotherapy? TNM classification, number of examined lymph nodes, MSI status, and presence or not of a perforation or a perinervous, lymphatic or venous invasion is recognized prognostic factors. Also, what are the alternatives of FOLFOX 4 regimen as colorectal cancer adjuvant treatment?

引用

页码：51 / 57

页数：7

共 36 条

[1] Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].

Andre, T ;

Boni, C ;

Mounedji-Boudiaf, L ;

Navarro, M ;

Tabernero, J ;

Hickish, T ;

Topham, C ;

Zaninelli, M ;

Clingan, P ;

Bridgewater, J ;

Tabah-Fisch, I ;

de Gramont, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351

[2]

[Anonymous], GASTR CANC S

[3] Cancer incidence and mortality in France over the period 1980-2005 [J].

Belot, A. ;

Grosclaude, P. ;

Bossard, N. ;

Jougla, E. ;

Benhamou, E. ;

Delafosse, P. ;

Guizard, A. -V. ;

Molinie, F. ;

Danzon, A. ;

Bara, S. ;

Bouvier, A. -M. ;

Tretarre, B. ;

Binder-Foucard, F. ;

Colonna, M. ;

Daubisse, L. ;

Hedelin, G. ;

Launoy, G. ;

Le Stang, N. ;

Maynadie, M. ;

Monnereau, A. ;

Troussard, X. ;

Faivre, J. ;

Collignon, A. ;

Janoray, I. ;

Arveux, P. ;

Buemi, A. ;

Raverdy, N. ;

Schvartz, C. ;

Bovet, M. ;

Cherie-Challine, L. ;

Esteve, J. ;

Remontet, L. ;

Velten, M. .

REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2008, 56 (03) :159-175

[4]

COHEN AM, 1991, CANCER, V67, P1859, DOI 10.1002/1097-0142(19910401)67:7<1859::AID-CNCR2820670707>3.0.CO

[5]

2-A

[6]

Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979

[7] How do gastroenterologists follow patients with colorectal cancer after curative surgical resection? A three-year population-based study [J].

Coriat, Romain ;

Mahboubi, Amel ;

Lejeune, Catherine ;

Bouvier, Anne-Marie ;

Bedenne, Laurent ;

Bonithon-Kopp, Claire .

GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2007, 31 (11) :950-955

[8] AVANT: Results from a randomized, three-arm multinational phase III study to investigate bevacizumab with either XELOX or FOLFOX4 versus FOLFOX4 alone as adjuvant treatment for colon cancer. [J].

De Gramont, A. ;

Van Cutsem, E. ;

Tabernero, J. ;

Moore, M. J. ;

Cunningham, D. ;

Rivera, F. ;

Im, S. ;

Makrutzki, M. ;

Shang, A. ;

Hoff, P. M. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)

[9] Association Between Disease-Free Survival and Overall Survival When Survival Is Prolonged After Recurrence in Patients Receiving Cytotoxic Adjuvant Therapy for Colon Cancer: Simulations Based on the 20,800 Patient ACCENT Data Set [J].

de Gramont, Aimery ;

Hubbard, Joleen ;

Shi, Qian ;

O'Connell, Michael J. ;

Buyse, Marc ;

Benedetti, Jacqueline ;

Bot, Brian ;

O'Callaghan, Chris ;

Yothers, Greg ;

Goldberg, Richard M. ;

Blanke, Charles D. ;

Benson, Al ;

Deng, Qiqi ;

Alberts, Steven R. ;

Andre, Thierry ;

Wolmark, Norman ;

Grothey, Axel ;

Sargent, Daniel .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) :460-465

[10] Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis [J].

Des Guetz, Gaetan ;

Schischmanoff, Olivier ;

Nicolas, Patrick ;

Perret, Gerard-Yves ;

Morere, Jean-Francois ;

Uzzan, Bernard .

EUROPEAN JOURNAL OF CANCER, 2009, 45 (10) :1890-1896

← 1 2 3 4 →